A detailed history of Calamos Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 397,752 shares of ADMA stock, worth $7.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
397,752
Previous 603,003 34.04%
Holding current value
$7.05 Million
Previous $6.74 Million 17.95%
% of portfolio
0.05%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$11.21 - $20.03 $2.3 Million - $4.11 Million
-205,251 Reduced 34.04%
397,752 $7.95 Million
Q2 2024

Jul 25, 2024

BUY
$5.98 - $11.18 $277,501 - $518,807
46,405 Added 8.34%
603,003 $6.74 Million
Q1 2024

May 08, 2024

BUY
$4.4 - $6.74 $1.35 Million - $2.07 Million
306,413 Added 122.47%
556,598 $3.67 Million
Q4 2023

Jan 31, 2024

BUY
$3.08 - $4.52 $424,266 - $622,625
137,749 Added 122.51%
250,185 $1.13 Million
Q3 2023

Oct 25, 2023

BUY
$3.47 - $4.61 $191,585 - $254,527
55,212 Added 96.48%
112,436 $402,000
Q2 2023

Jul 28, 2023

BUY
$3.12 - $4.22 $178,538 - $241,485
57,224 New
57,224 $211,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.48B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.